SCWorx Corp. (WORX) Stock Score, Valuation & Financial Research

SCWorx Corp. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 15/100.

Quick answer for WORX

SCWorx Corp. currently has a Wall Street Score of 15/100. The stored market price is USD 4.20. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What SCWorx Corp. does

SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States. The company delivers a broad spectrum of data-focused services, encompassing the repair, standardization, and interoperability of healthcare information for providers, alongside delivering sophisticated big data analytics for the sector. Its diverse offerings include virtualized item master file repair, expansion, and automation; management of electronic medical records (EMR) and charge description masters (CDM); optimization of contract management; automation of request for proposal (RFP) and rebate processes; integration of acquired management systems; big data analytics modeling; data integration and warehousing; and its proprietary ScanWorx solution. Beyond its core healthcare IT endeavors, SCWorx has diversified into other areas. It operates CageTix, an online event ticketing platform specifically targeting regional mixed martial arts events. Additionally, the company is involved in the provision of personal protective equipment (PPE) and rapid COVID-19 test kits. SCWorx distributes its specialized solutions and services to hospitals and health systems through a multi-channel approach, leveraging both its internal sales team and strategic distribution and reseller partnerships.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

SCWorx generates revenue primarily through software-as-a-service (SaaS) subscriptions and professional services. The company provides healthcare providers with data content and software modules that normalize, automate, and repair foundational business data, such as item master files and charge description masters, to improve billing accuracy and reduce operational costs.

Products and services

  • Healthcare information technology solutions including virtualized Item Master File repair, CDM management, contract management, request for proposal automation, rebate management, big data analytics modeling, and EMR integration.

Customer types

Healthcare providers.

Business strengths to evaluate

  • Advanced data normalization and interoperability capabilities for healthcare business applications Source

Business risks and research considerations

  • History of operating losses and potential inability to maintain sufficient capital to continue as a going concern Source
  • Significant customer concentration risk Source

Sources: Company research source

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

WORX financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
15/100
Stored price:
USD 4.20
Market capitalization:
67.2M (currency not supplied)
Revenue:
USD 2.93M
Net income:
USD -2.36M
Free cash flow:
USD -1.55M
Cash:
USD 1.26M
Total debt:
USD 1.54K
EPS:
USD -4.47
Financial score:
25/100
Valuation score:
0/100
Revenue score:
2/100

What stands out

  • Reported year-over-year revenue growth is +1.7%.
  • Free cash flow is USD -1.55M, negative for the stored period.
  • The balance sheet shows USD 1.26M of cash versus USD 1.54K of total debt, an excess of cash over debt on these two reported measures.
  • The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Free cash flow is -53.1% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
  • Net income equals -80.5% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
  • Cash exceeds debt by USD 1.26M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for WORX

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • Can WORX maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • How long can WORX fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is WORX likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for WORX to reach sustainable profitability?
  • What future growth or profitability would be needed to justify WORX's current valuation?

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-08.

Research-input completeness: 100% of the scoring inputs required for this public page are currently available.

How to research WORX

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.